MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.9942
+0.0732 (7.95%)
At close: Apr 24, 2025, 4:00 PM
1.000
+0.006 (0.58%)
Pre-market: Apr 25, 2025, 5:37 AM EDT

MIRA Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
4.716.954.71.470.16
Research & Development
3.311.572.350.680.04
Operating Expenses
8.028.537.052.150.2
Operating Income
-8.02-8.53-7.05-2.15-0.2
Interest Expense
--3.46-0.01-0.02-0
Interest & Investment Income
0.17----
Pretax Income
-7.85-11.98-7.06-2.18-0.2
Net Income
-7.85-11.98-7.06-2.18-0.2
Net Income to Common
-7.85-11.98-7.06-2.18-0.2
Shares Outstanding (Basic)
15141813-
Shares Outstanding (Diluted)
15141813-
Shares Change (YoY)
10.91%-20.73%38.60%--
EPS (Basic)
-0.51-0.86-0.40-0.17-
EPS (Diluted)
-0.51-0.86-0.40-0.17-
EBIT
-8.02-8.53-7.05-2.15-0.2
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q